Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Christopher Moxham > Profile

Christopher Moxham

Affiliations

Chief Scientific Officer at Fulcrum Therapeutics Inc. (FULC), 2021-08-12

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
FULC	$18.00	31,071	$559,278.00	0	2021-08-10	Filing
FULC	$17.00	20,714	$352,138.00	0	2021-08-10	Filing